Biopharmaceuticals Global Business Report 2024 with Focus on 200+ Select Players Including Abbott, Amgen, Biogen, Eli Lilly and Co, F. Hoffmann-La Roche, J&J, Merck, Novo Nordisk, Pfizer, Sanofi
August 23, 2024 07:20 ET
|
Research and Markets
Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
Cancer Engineered Antibody Therapeutics Market Analysis 2024: Technology Advances and Increasing Interest from Tier I Pharmaceuticals Driving Growth of Engineered Antibodies
August 15, 2024 07:35 ET
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Engineered Antibody Therapeutics for Cancer" report has been added to ResearchAndMarkets.com's offering.This study analyzes the emergence of...
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
August 13, 2024 16:05 ET
|
Dyadic International, Inc.
Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and BiologicalsEntered into a joint...
Anti TIGIT Antibodies Clinical Trials Market Outlook to 2028: Insight on 50+ Anti TIGIT Antibodies in Clinical Trials
August 09, 2024 05:22 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Anti TIGIT Antibodies Clinical Trials & Market Opportunity Outlook 2028" report has been added to ResearchAndMarkets.com's offering. Anti TIGIT...
Trispecific Antibodies Clinical Trials & Market Outlook Report 2024: Innovative Trispecific Antibody Therapy - A New Frontier in Cancer and Disease Treatment
August 09, 2024 04:19 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibodies Clinical Trials & Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering.The blueprint in...
Multispecific Antibodies Market Research, Drug Sales, Price & Clinical Trials Insights 2023-2029: 13 Approved, 900 Multispecific Antibodies in Clinical Trials by Company, Country, Indication, & Phase
August 09, 2024 04:16 ET
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029" report has been added to ResearchAndMarkets.com's...
Research Antibodies Market Research - Global Forecasts from 2024 to 2029: Expanding Requirement for Personalised Medication and Structure-based Medication Plans to Bolster Growth
June 24, 2024 10:17 ET
|
Research and Markets
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Research Antibodies Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The global research...
$1.9 Billion Biopharmaceuticals Manufacturing Consumables Testing Market Report, 2034: Global and Regional Data Projections by Type, Raw Material, Application, and End-user
June 13, 2024 05:16 ET
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Biopharmaceuticals Manufacturing Consumables Testing Market" report has been added to ResearchAndMarkets.com's offering.The global...
Global Monoclonal Antibodies Market Report 2024-2032, by Production Method, Source, Indication, End Use and Region
June 12, 2024 11:25 ET
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies Market Report by Production Method, Source, Indication, End Use, and Region 2024-2032" report has been added to ...
Trispecific Antibodies Set to Transform the Future of Immunotherapy: Trispecific Antibodies Clinical Trials Insight by Company, Country, Indication & Phase
June 07, 2024 02:59 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global Trispecific Antibodies Clinical Trials & Market Outlook 2024" report has been added to ResearchAndMarkets.com's offering. The blueprint...